Nicotine e-cigarettes outperform patches and gum for quitting smoking

Researchers have found that nicotine e-cigarettes help more smokers quit than traditional nicotine replacement therapies like patches and gum. A review of 14 systematic studies from 2014 to 2023 shows consistent high-quality evidence favoring nicotine vapes. The findings highlight gaps in research on long-term risks and comparisons to other treatments.

A team led by Dr. Angela Difeng Wu from the University of Oxford's Nuffield Department of Primary Care Health Sciences analyzed 14 systematic reviews on smoking cessation methods. The highest-quality studies consistently demonstrated higher quit rates with nicotine e-cigarettes compared to nicotine patches, gum, lozenges, non-nicotine e-cigarettes, and behavioral support programs alone. Lower-quality research showed more mixed results, but the strongest evidence supports nicotine e-cigarettes as more effective. The work, published in the journal Addiction, was funded by Cancer Research UK. Dr. Wu stated, 'We hope this overview and Evidence and Gap Map can lay to rest some claims that evidence is mixed regarding the impacts of nicotine e-cigarettes on smoking abstinence. In fact, the evidence is clear and consistent across all of the meta-analyses we consulted: e-cigarettes are effective at helping people stop smoking.' Researchers created an Evidence and Gap Map to identify research needs. No high-quality reviews compare nicotine e-cigarettes to cytisine, bupropion, or nicotine pouches, and evidence against varenicline comes from just one small, high-bias study. Data on serious adverse events remains uncertain, and most studies focus on high-income countries. The authors call for more research on risks and diverse populations.

Related Articles

Illustration of young non-smoking lung cancer patient enjoying high-quality healthy diet of fruits, vegetables, and whole grains, with charts showing above-average scores and subtle pesticide exposure hints.
Image generated by AI

Study of young lung cancer patients finds unexpectedly high diet-quality scores; researchers probe possible pesticide exposure

Reported by AI Image generated by AI Fact checked

Preliminary research from USC Norris Comprehensive Cancer Center, presented at the American Association for Cancer Research (AACR) annual meeting, found that non-smokers diagnosed with lung cancer before age 50 reported eating more fruits, vegetables and whole grains—and had higher overall Healthy Eating Index scores—than the U.S. population average. The researchers emphasized that the results do not prove diet causes lung cancer and said a possible explanation could involve environmental exposures such as pesticides, a hypothesis that requires direct testing.

Hong Kong authorities will target flavoured tobacco in the next phase of smoking controls, health chief Lo Chung-mau said on Saturday. He called flavoured e-cigarettes a poisoned chalice designed to hook young people.

Reported by AI

A member of Indonesia's DPR Commission III from PKB faction, Abdullah, has warned against rushing a total ban on electronic cigarettes despite the National Narcotics Agency finding narcotics in hundreds of illegal liquid samples. He stressed the need for thorough studies to protect small businesses and users. Meanwhile, a NasDem faction member supports BNN's ban proposal.

Researchers at Tokyo University of Science have discovered that combining common plant compounds from mint, eucalyptus, and chili peppers dramatically enhances their anti-inflammatory effects in immune cells. Certain pairings amplified the response several hundred-fold compared to individual use. The findings, published in the journal Nutrients, suggest potential for new dietary approaches to combat chronic inflammation.

Reported by AI

A new review of clinical trials suggests that psychedelics like psilocybin are effective for treating depression but offer no advantage over traditional antidepressants. Researchers accounted for the challenge of blinding in psychedelic studies, where participants can often tell if they received the drug. The findings indicate similar outcomes when compared to unblinded antidepressant trials.

This website uses cookies

We use cookies for analytics to improve our site. Read our privacy policy for more information.
Decline